Cell line · CVCL_ZC87
LNCaP-95
Cancer cell line, Homo sapiens. Prostate carcinoma. 13 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. LNCaP-95. Cell lines, record CVCL_ZC87. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_ZC87
On this page
Cell line
As Cellosaurus gives it.
- Name
- LNCaP-95
- Accession
- CVCL_ZC87
- RRID
- RRID:CVCL_ZC87
- Synonyms
- LNCaP 95, LNCaP95, LN95
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 50Y
- Category
- Cancer cell line
- Diseases
- Prostate carcinoma (NCIt C4863)
- Derived from
- Left supraclavicular lymph node (metastatic)
- Parent
- LNCaP clone FGC (CVCL_1379)
- Entry created
- 2020-07-02
- Entry updated
- 2024-12-19
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers13
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Co-Targeting Nuclear Export and Translation Initiation Uncovers a Therapeutic Vulnerability in Lethal Prostate Cancer. | bioRxiv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Direct Co-Targeting of Bcl-xL and Mcl-1 Exhibits Synergistic Effects in AR-V7-Expressing CRPC Models. | Cancer Res Commun | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Defining Splicing Factor Requirements for Androgen Receptor Variant Synthesis in Advanced Prostate Cancer. | Mol Cancer Res | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Genomic Characterization of Preclinical Prostate Cancer Cell Line Models. | Int J Mol Sci | 2024 | Cellosaurus cites it, and its Methods give the RRID and name the line | PubMed | |
| A Compound That Inhibits Glycolysis in Prostate Cancer Controls Growth of Advanced Prostate Cancer. | Mol Cancer Ther | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Concurrent Targeting of HDAC and PI3K to Overcome Phenotypic Heterogeneity of Castration-resistant and Neuroendocrine Prostate Cancers. | Cancer Res Commun | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Systematic study of tissue factor expression in solid tumors. | Cancer Rep (Hoboken) | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling. | Cancer Res | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Assessment of Androgen Receptor Splice Variant-7 as a Biomarker of Clinical Response in Castration-Sensitive Prostate Cancer. | Clin Cancer Res | 2022 | Its Methods give the RRID and name the line | PubMed | |
| G3BP1 inhibits Cul3SPOP to amplify AR signaling and promote prostate cancer. | Nat Commun | 2021 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 13
See all 13 papersRelatives8
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Parent | LNCaP clone FGC | CVCL_1379 | Cell lines | |
| Derived from it | LNCaP95 clone 2-C6 | CVCL_A4DX | Cell lines | |
| Derived from it | LNCaP95 clone 2-D3 | CVCL_A4DY | Cell lines | |
| Derived from it | LNCaP95 clone A7 | CVCL_A4DZ | Cell lines | |
| Derived from it | LNCaP95 clone D2 | CVCL_A4EA | Cell lines | |
| Derived from it | LNCaP95 clone D3 | CVCL_A4EB | Cell lines | |
| Derived from it | LNCaP95 clone E2 | CVCL_A4EC | Cell lines | |
| Derived from it | LNCaP95 clone F2 | CVCL_A4ED | Cell lines |
Cell banks0
None in this release.
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_ZC87
GET https://conductscience.org/api/cell-lines/v1/CVCL_ZC87/problems